Chile vs Guadeloupe: Brain and nervous system cancer death rate
Chile
2.35 deaths per 100,000 people
in 2022
Guadeloupe
2.45 deaths per 100,000 people
in 2016
Chile rank
75th
Guadeloupe rank
74th
Brain and nervous system cancer death rate over time
- Chile
- Guadeloupe
How they compare
Guadeloupe currently reports 2.45 deaths per 100,000 people against 2.35 deaths per 100,000 people in Chile, a difference of 0.1 deaths per 100,000 people.
The two have swapped places 7 times across 17 shared years of data; in 2000 it was Chile ahead.
Chile ranks 75th and Guadeloupe ranks 74th of 111 countries.
Chile has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Guadeloupe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.84 deaths per 100,000 people | 1.77 deaths per 100,000 people | 0.0696 deaths per 100,000 people | Chile |
| 2010s | 2.27 deaths per 100,000 people | 2.2 deaths per 100,000 people | 0.0724 deaths per 100,000 people | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher brain and nervous system cancer death rate, Chile or Guadeloupe?
- Guadeloupe, at 2.45 deaths per 100,000 people against 2.35 deaths per 100,000 people in Chile as of 2016.
- What is the difference in brain and nervous system cancer death rate between Chile and Guadeloupe?
- 0.1 deaths per 100,000 people, with Guadeloupe ahead.
- How many years of comparable data are there for Chile and Guadeloupe?
- 17 years are reported by both, from 2000 to 2016.
- How do Chile and Guadeloupe rank globally for brain and nervous system cancer death rate?
- Chile ranks 75th and Guadeloupe ranks 74th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Brain and nervous system cancer death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from brain and nervous system cancers in both sexes in those aged all ages per 100,000 people.